United Therapeutics (UTHR) Equity Income (2009 - 2013)
United Therapeutics' (UTHR) quarterly Equity Income came in at -$72000.0 in Q2 2013, down 71.43% year-over-year from -$252000.0 in Q2 2012, and down 53.19% quarter-over-quarter from -$47000.0 in Q1 2013.
Powered by 
Analysis
United Therapeutics (UTHR) Equity Income (2009 - 2013) Analysis & Trends
United Therapeutics has disclosed Equity Income across 5 years of filings, most recently posting -$72000.0 for Q2 2013.
- In Q2 2013, Equity Income fell 71.43% year-over-year to -$72000.0; the TTM figure through Jun 2013 stood at -$200000.0 (down 75.44% YoY), while the FY2012 annual figure was -$143000.0, down 20.17% from the prior year.
- Equity Income came in at -$72000.0 for Q2 2013 at United Therapeutics, down from -$47000.0 in the prior quarter.
- In the past five years, Equity Income ranged from a high of -$9000.0 in Q4 2011 to a low of -$72000.0 in Q2 2013.
- Average Equity Income over 5 years is -$39000.0, with a median of -$42000.0 recorded in 2009.
- Year-over-year, Equity Income soared 70.0% in 2011 and sank 266.67% in 2012.
- Over 5 years, Equity Income stood at -$42000.0 in 2009, then increased by 28.57% to -$30000.0 in 2010, then soared by 70.0% to -$9000.0 in 2011, then slumped by 266.67% to -$33000.0 in 2012, then slumped by 118.18% to -$72000.0 in 2013.
- Per Business Quant data, the three most recent Equity Income figures were -$72000.0 in Q2 2013, -$47000.0 in Q1 2013, and -$33000.0 in Q4 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | - |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | - |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | -2.00 Mn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | -10.46 Mn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | - |
| 10 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2013 | -72,000.00 |
| Mar 31, 2013 | -47,000.00 |
| Dec 31, 2012 | -33,000.00 |
| Sep 30, 2012 | -48,000.00 |
| Jun 30, 2012 | -42,000.00 |
| Mar 31, 2012 | -20,000.00 |
| Dec 31, 2011 | -9,000.00 |
| Sep 30, 2011 | -43,000.00 |
| Jun 30, 2011 | -30,000.00 |
| Mar 31, 2011 | -37,000.00 |
| Dec 31, 2010 | -30,000.00 |
| Sep 30, 2010 | -39,000.00 |
| Jun 30, 2010 | -44,000.00 |
| Mar 31, 2010 | -47,000.00 |
| Dec 31, 2009 | -42,000.00 |
| Sep 30, 2009 | -42,000.00 |
| Jun 30, 2009 | -38,000.00 |